Zevra
Zevra Therapeutics is leading in rare disease therapeutics, involving key stakeholders in clinical and regulatory strategies. They are expanding their team to include a Director of Global Patient Advocacy, who will develop and oversee patient advocacy initiatives, build relationships with advocacy groups, and promote patient-centric culture within the organization.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2006
Zevra Therapeutics is a commercial-stage rare disease company focused on developing and commercializing therapies for people living with rare diseases. The company advances treatments for serious, underserved conditions and works to address unmet medical needs through clinical development and commercialization.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zevra.
Zevra didn’t post a salary, so this is our estimate from similar listings.
3% below the average for this role
Associate Director, Patient Advocacy - Canada
argenx
Senior Manager, Patient Advocacy
PharmaEssentia
Associate Director, Patient Advocacy
talisman corporation
Associate Director, Global Patient Advocacy
Regeneron Pharmaceuticals
Director, Global Patient Advocacy Lead
American Association of Physicists in Medicine
Director, Patient Advocacy
AstraZeneca